The study observed significant elevations in IL-6 (p < 0.001), IL-10 (p < 0.001), and IFN-γ (p = 0.023) in B-ALL patients, alongside a marked reduction in TGF-β1 (p = 0.001). This evidence concerns the gene TGFB1 and precursor B-cell acute lymphoblastic leukemia.